Plasmin-anti-plasmin levels were shown to be increased in patients with chronic inflammatory disorders such as systemic sclerosis [8], systemic lupus erythematosus, arthritis and other forms of collagen diseases [42]. Here, PLG is linked to rheumatic disorder.